Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

Exosens Q3 revenue rises 23.5% on stronger demand, capacity ramp-up

By Reuters News

Oct 26 (Reuters) - French detection and imaging technology company Exosens EXENS.PA on Tuesday posted a 23.5% rise in its third-quarter revenue, driven by stronger demand for its products and faster-than-expected European capacity ramp-up.

The company, which develops imaging sensors and detection systems for defence, nuclear and life-science markets, has benefited from strong demand due to higher global defence spending.

  • Exosens reported revenue of €386.9 million ($432 million) for the first nine months of 2026, up 18% from a year earlier

  • The group confirmed its 2026 guidance, which it had upgraded twice this year

  • It said it was on track to increase its image intensifier tube capacity by 40% in Europe and the US by 2027, and meet its capacity targets for thermal and cooled infrared cameras

  • CEO Jerome Cerisier said that additional European capacity for image intensifier tubes, used to make night vision goggles for the military, was ramping up ahead of plan



($1 = 0.8946 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.